Kaitlyn Tsuruda is a statistician and data manager in the Research Department's Section for Administration and Research Support. She supports researchers in different stages of the research process: from data management and documentation to statistical analyses and data interpretation, as well as manuscript writing. Kaitlyn is an epidemiologist by training and holds a PhD from the University of Oslo.
Kaitlyn is a statistician and data manager in the Research Department's Section for Administration and Research Support. She supports researchers in different stages of the research process: from data management and documentation to statistical analyses and data interpretation, as well as manuscript writing. Her current work involves supporting classical- and pharmacoepidemiology research related primarily to breast, prostate, and lung cancer.
Kaitlyn is an epidemiologist by training and an accredited Associate Statistician with the Statistical Society of Canada. Her PhD thesis at the University of Oslo evaluated possible risks associated with mammography screening. She holds an MSc in Community Health and Epidemiology from Dalhousie University and a BSc in Mathematics from Saint Mary's University, both in Halifax, Canada.
Prior to joining the Research Department, Kaitlyn worked with research and quality assurance in the Mammography Section (2016-2017; 2021) and as a statistician in the Registry Section with the quality registries for breast and gynecological cancers (2018). Prior to that, she worked as an epidemiologist at a Canadian company developing artificial intelligence-based solutions for breast cancer screening.
Robsahm TE, Tsuruda KM, Hektoen HH, Storås AH, Cook MB, Hurwitz LM, Langseth H (2023) Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway, Acta Oncol. DOI 10.1080/0284186X.2023.2175331 PubMed 36762472 https://pubmed.ncbi.nlm.nih.gov/36762472/
Tsuruda KM, Larsen M, Roman M, Hofvind S. (2021) Cumulative risk of a false-positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway. Cancer. DOI 10.1002/cncr.34078, PubMed 34931707
Tsuruda KM, Hovda T, Bhargava S, Veierød MB, Hofvind S. (2021) Survival among women diagnosed with screen-detected or interval breast cancer classified as true, minimal signs, or missed through an informed radiological review. Eur Radiol. 31(5):2677-2686. DOI 10.1007/s00330-020-07340-4, PubMed: 33180162
